Pharmaceutical Investing 3D Signatures Strengthens Its Intellectual Property With New Patents Issued for Tests in Alzheimer’s Disease, Hodgkin’s Lymphoma and Multiple Myeloma
Isodiol International Inc. Announces Letter of Intent to Supply 99.5%+ Pharma-Grade Cannabidiol to Zenabis
Pharmaceutical Investing Madrigal Pharmaceuticals Reports 2018 First Quarter Financial Results and Reviews Key Clinical Achievements
Pharmaceutical Investing scPharmaceuticals Reports First Quarter 2018 Financial Results and Provides Business Update
Isodiol International Inc. Announces Letter of Intent to Supply 99.5%+ Pharma-Grade Cannabidiol to Zenabis
Cannabis Investing Isodiol Receives Government Approval for Pure, Natural CBD as an Active Pharmaceutical Ingredient
Pharmaceutical Investing Reata Announces New Preclinical Data Demonstrating the Potential of Omaveloxolone
Cannabis Investing Kalytera Announces Next Payment in Shares under Services Agreement with Salzman Group
Pharmaceutical Investing Clementia Initiates Phase 2 MO-Ped Trial for Palovarotene in Patients with Multiple Osteochondromas
